Dutch-based Ansana bags €1.5M to make hospital surgeries safer with its smart sterilisation technology
Dutch-based Ansana raises funds to advance SteriWatch, its sterilisation system designed to enhance hospital workflows and patient safety.
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
Dutch-based Ansana raises funds to advance SteriWatch, its sterilisation system designed to enhance hospital workflows and patient safety.
Amsterdam-based Clear.bio, a healthtech startup focused on personalised diabetes care, has secured €1.7M in a fresh funding round.
Dutch medtech company Sencilia secures fresh funding to support the development of its infusion therapy technology.
Toothfairy has raised funding to expand its app that connects patients with dentists for remote consultations and treatment monitoring.
The Hague-based Carepool is developing an app designed to assist individuals with personal budgets in searching for, planning, and managing their care.
ViCentra, maker of the Kaleido insulin patch pump, has closed a Series D funding round from new and existing investors.
Paris-based ArcaScience, the AI healthtech startup, has raised $7M (approximately €6M) in a seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies.
Cologne-based Detechgene, a spin-off of the Nephrolab of the University Hospital Cologne Medicine II, announced the completion of its second seed financing round, raising €3.2M funding.
Munich-based Ortivity, a company specialised in outpatient orthopaedic care, has received €200M funding led by Apheon, a pan-European private equity investor, with participation from Unigestion and other new investors.
The Kuopio-based medtech company raised €2.5M funding to bring a breakthrough therapy closer to patients suffering from brain tumours.
A US-based firm specialised in improving care for musculoskeletal (MSK) conditions announced the acquisition of this Amsterdam-based AI-powered digital health company.
Copenhagen-based SNIPR Biome, a biotech company focused on developing precision medicines through CRISPR technology for microbial gene therapy, has successfully secured €35M in a Series B funding round.